The Lancet Oncology CommissionProgress and remaining challenges for cancer control in Latin America and the Caribbean
Section snippets
Part 1: Introduction
Our previous 2013 Commission1 on cancer care in Latin America showed the existing and increasing burden of cancer in the region and identified several obstacles to providing optimum cancer services. Although some cancer incidences are lower in developed countries than in Latin American countries, overall cancer mortality in Latin American countries is about twice that of more developed countries. Ageing of the Latin American population, which will include more than 100 million people by 2020
Part 2: Fragmented health systems
Originally, Latin American health systems sought to enrol salaried workers.23 With this scenario, universal health care would hopefully be gradually achieved through economic, professional, and social development. Unfortunately, this situation has not been the case in most of Latin America, where development did not create enough employment opportunities in the formal sector.24 Health system fragmentation refers to a coexistence of subsystems with different modalities of financing, affiliation,
Part 3: Palliative care
Since 2013, a major advance in the specialty of palliative care in Latin America has been the publication of the Atlas of Palliative Care in Latin America by the Latin American Association for Palliative Care (Asociación Latinoamericana de Cuidados Paliativos).5 The Atlas is the first systematic gathering of information on the status of palliative care in Latin America, and it represents cooperation between different institutions worldwide including the International Association for Hospice and
Part 4: National cancer plans and cancer registries
In the 2011 country profiles for non-communicable diseases, WHO reported that 52% of Latin American and Caribbean countries had an integrated policy, or programme, or action plan for cancer.70 For 2014, WHO reported an 8% increase in the number of countries (60% of the whole region) with an NCCP,71 with these countries having newly adopted plans: Suriname, Ecuador, Dominican Republic, Trinidad and Tobago, Puerto Rico, Peru, El Salvador, and Colombia (figure 1). Belize has established the plan
Part 5: Financing of cancer care
The IMS Institute for Healthcare and Informatics forecasts that for 2016, worldwide expenditure for medicines will be US$1·2 trillion ($615–645 billion spent on branded drugs and $400–430 billion spent on generics); 30% of this expenditure will be from pharmerging markets (in 2012 this amount was 20%).12 Thus, although the USA is expected to increase its spending on drugs by 1–4%, pharmerging countries are expected to increase their expenditures by 12–15%, primarily on cancer care.12
Between
Part 6: Training in oncology and palliative care
Since our previous Commission, awareness about the shortage of cancer specialists has increased in Latin American countries, driven partly by meetings such as the PAHO-initiated conference entitled “Innovative cervical and breast cancer control strategies”, in which increases in oncological training for medical and non-medical personnel in both screening and diagnostic testing was strongly recommended.120
Subsequently, the number of oncologists across Latin America has steadily increased, most
Part 7: Disparities in cancer control
Although numerous efforts to overcome cancer inequalities have been undertaken in the Latin American region in the past few years, inequities in cancer care persist, which have been discussed in several studies published since 2012 (table 6).139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154 We report on several initiatives to overcome these inequalities.
Part 8: Causes of cancer that are of specific concern to Latin America
Among behavioural and environmental risk factors that have a role in the cause of cancer in Latin American populations, several are of special importance because they cause a large proportion of cancer-associated morbidity, particularly in less developed countries in the region. These risk factors include: (1) tobacco use causing lung cancer, which is anticipated to emerge as the main killer in the region if smoking rates do not decrease;187 (2) indoor smoke (panel 3), which is the leading
Part 9: Continuing challenges and remaining questions
Although progress has been made, obstacles to Latin American health systems identified by our 2013 Commission remain. There has been progress towards universal health care, but the number of people with a minimum benefit scheme covering short-term interventions has continued segregating social groups into health-system fragments: a well-funded social security system for employed workers and their families; and a public system providing only basic, poor quality services for the unemployed or the
References (264)
- et al.
Planning cancer control in Latin America and the Caribbean
Lancet Oncol
(2013) - et al.
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
Lancet Oncol
(2012) - et al.
Global health 2035: a world converging within a generation
Lancet
(2013) - et al.
Inequalities in non-communicable diseases and effective responses
Lancet
(2013) - et al.
Wood-smoke exposure as a response and survival predictor in erlotinib-treated nonsmall cell lung cancer patients
J Thorac Oncol
(2009) - et al.
Wood-smoke exposure as a response and survival predictor in erlotinib-treated non-small cell lung cancer patients: an open label phase II study
J Thorac Oncol
(2008) - et al.
Health-system reform and universal health coverage in Latin America
Lancet
(2015) - et al.
Outcomes of Hispanic women with lymph-node positive, HER2 positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab in Mexico
Breast
(2015) - et al.
Overcoming social segregation in health care in Latin America
Lancet
(2015) - et al.
Universal health coverage in Latin American countries: how to improve solidarity-based schemes
Lancet
(2015)